Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 1
1967 2
1968 1
1969 1
1970 2
1971 4
1972 6
1973 5
1974 9
1975 6
1976 4
1977 5
1978 13
1979 11
1980 9
1981 12
1982 6
1983 10
1984 11
1985 15
1986 33
1987 10
1988 14
1989 19
1990 13
1991 13
1992 8
1993 21
1994 11
1995 18
1996 27
1997 9
1998 15
1999 13
2000 17
2001 14
2002 28
2003 18
2004 29
2005 31
2006 21
2007 12
2008 19
2009 35
2010 32
2011 25
2012 35
2013 18
2014 19
2015 15
2016 23
2017 56
2018 38
2019 40
2020 40
2021 41
2022 36
2023 29
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

982 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Among authors: kamata k. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407).
Ozaka M, Nakachi K, Kobayashi S, Ohba A, Imaoka H, Terashima T, Ishii H, Mizusawa J, Katayama H, Kataoka T, Okusaka T, Ikeda M, Sasahira N, Miwa H, Mizukoshi E, Okano N, Mizuno N, Yamamoto T, Komatsu Y, Todaka A, Kamata K, Furukawa M, Fujimori N, Katanuma A, Takayama Y, Tsumura H, Fukuda H, Ueno M, Furuse J; Hepatobiliary and Pancreatic Oncology Group of Japan Clinical Oncology Group (JCOG). Ozaka M, et al. Among authors: kamata k. Eur J Cancer. 2023 Mar;181:135-144. doi: 10.1016/j.ejca.2022.12.014. Epub 2022 Dec 27. Eur J Cancer. 2023. PMID: 36652891 Free article. Clinical Trial.
Gaiter of pellagra.
Munakata K, Kamata K, Yamanaka K. Munakata K, et al. Among authors: kamata k. QJM. 2023 Feb 24;116(2):134-135. doi: 10.1093/qjmed/hcac222. QJM. 2023. PMID: 36106995 No abstract available.
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: kamata k. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666 Free article. Clinical Trial.
Intestinal Dysbiosis and Autoimmune Pancreatitis.
Yoshikawa T, Watanabe T, Kamata K, Hara A, Minaga K, Kudo M. Yoshikawa T, et al. Among authors: kamata k. Front Immunol. 2021 Mar 23;12:621532. doi: 10.3389/fimmu.2021.621532. eCollection 2021. Front Immunol. 2021. PMID: 33833754 Free PMC article. Review.
Response.
Kitano M, Imai H, Kamata K, Kudo M. Kitano M, et al. Among authors: kamata k. Gastrointest Endosc. 2016 Jun;83(6):1303. doi: 10.1016/j.gie.2016.03.1487. Gastrointest Endosc. 2016. PMID: 27206596 No abstract available.
Multiple gout tophi.
Nagano H, Kamata K, Tokuda Y. Nagano H, et al. Among authors: kamata k. QJM. 2018 Jun 1;111(6):419-420. doi: 10.1093/qjmed/hcy002. QJM. 2018. PMID: 29325095 No abstract available.
982 results